Support the redevelopment of SCARD
As we reflect on the inaugural year of Skin Cancer Audit and Research Data Inc (SCARD Inc), we announce the official recognition as a Charity.
SCARD Inc is the next evolution of the Skin Cancer Audit and Research Database, also known as the SCARD Surgical Audit.
The Journey of Transformation: Company to Charity
As we reflect on the inaugural year of Skin Cancer Audit and Research Data Inc (SCARD Inc), we announce the official recognition as a Charity.
A joint announcement between SCARD Systems and SCARD Inc
As we reflect on the inaugural year of Skin Cancer Audit and Research Data Inc (SCARD Inc), we announce the official recognition as a Charity.
2023 – A year in review for SCARD
As our founding year, 2023 has been a pivotal year for SCARD, marked by significant advancements in skin cancer research, data analysis, and medical practice. The articles published on the SCARD website throughout the year offer valuable insights into various aspects of skin cancer management.
The Crucial Role of Regular Skin Checks
In the realm of skin health, vigilance is key, and one of the most effective tools in the arsenal against skin cancer is the regular skin checks.
Visualizing data from SCARD
Medical professionals constantly grapple with a wealth of information,. How they digest and utilize this data can have a profound impact on patient outcomes.
The power of silicon
Medical research in the field of skin cancer relies on significant computing power to process and analyse vast amounts of complex data. As skin cancer cases increase, more computational resources are needed to make meaningful strides in improving diagnostic accuracy and treatment options.
Data security: the platforms behind SCARD
With regular reports of data breaches worldwide, security and compliance are a continuous focus of Skin Cancer Audit and Research Data Inc for the deidentified skin cancer results and databases we maintain.
This article is intended to provide information on the technology used by SCARD Inc for the collection and storage of data as well as the security and compliance measures undertaken.
Is photographic surveillance in melanoma diagnosis dispensable?
Thank you for the opportunity to respond to Melanoma diagnosis at a specialist dermatology practice without the use of photographic surveillance.
In this study, the authors provide an interesting descriptive report on a private dermatology practice in Brisbane, Queensland, Australia, practising without photographic surveillance.
Practitioner characteristics, diagnostic accuracy metrics and discovering-individual
The fifth publication utilizing SCARD (and part of 3 papers by the same research team) was published in April 2023 with the Australasian Journal of Dermatology